75 related articles for article (PubMed ID: 18790251)
1. Osteoporosis after kidney transplantation: preliminary report from a single center.
Wang HH; Chang PC; Chu SH; Liu KL; Lai PC; Huang JY; Chiang YJ
Transplant Proc; 2008 Sep; 40(7):2412-3. PubMed ID: 18790251
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of osteoporosis, osteopenia, and vertebral fractures in long-term renal transplant recipients.
Marcén R; Caballero C; Uriol O; Fernández A; Villafruela JJ; Pascual J; Martins J; Rodriguez N; Burgos FJ; Ortuño J
Transplant Proc; 2007 Sep; 39(7):2256-8. PubMed ID: 17889156
[TBL] [Abstract][Full Text] [Related]
3. Treatment of osteopenia and osteoporosis after kidney transplantation.
Grotz WH; Rump LC; Niessen A; Schmidt-Gayk H; Reichelt A; Kirste G; Olschewski M; Schollmeyer PJ
Transplantation; 1998 Oct; 66(8):1004-8. PubMed ID: 9808483
[TBL] [Abstract][Full Text] [Related]
4. Treatment of osteopenia and osteoporosis in renal transplant children and adolescents.
El-Husseini AA; El-Agroudy AE; El-Sayed MF; Sobh MA; Ghoneim MA
Pediatr Transplant; 2004 Aug; 8(4):357-61. PubMed ID: 15265162
[TBL] [Abstract][Full Text] [Related]
5. Comparison of bone mineral density with dual energy x-ray absorptiometry, quantitative ultrasound and single energy x-ray absorptiometry.
El-Desouki MI; Sherafzal MS; Othman SA
Saudi Med J; 2005 Sep; 26(9):1346-50. PubMed ID: 16155646
[TBL] [Abstract][Full Text] [Related]
6. [Effects of salmon calcitonin in treatment of osteoporosis in patients undergoing dialysis].
Wang SX; Li H
Zhonghua Yi Xue Za Zhi; 2008 Feb; 88(6):387-90. PubMed ID: 18581891
[TBL] [Abstract][Full Text] [Related]
7. Quantitative ultrasound of the calcaneus in long-term liver or cardiac transplantation patients.
Díaz-Guerra GM; Gil-Fraguas L; Jódar E; Meneu JC; García E; Gómez MA; Moreno E; Hawkins F
J Clin Densitom; 2006; 9(4):469-74. PubMed ID: 17097534
[TBL] [Abstract][Full Text] [Related]
8. Osteoporosis and related risk factors in renal transplant recipients.
Ahmadpoor P; Reisi S; Makhdoomi K; Ghafari A; Sepehrvand N; Rahimi E
Transplant Proc; 2009 Sep; 41(7):2820-2. PubMed ID: 19765445
[TBL] [Abstract][Full Text] [Related]
9. Bisphosphonates are effective prophylactic of early bone loss after renal transplantation.
Nowacka-Cieciura E; Cieciura T; Baczkowska T; Kozińska-Przybył O; Tronina O; Chudziński W; Pacholczyk M; Durlik M
Transplant Proc; 2006; 38(1):165-7. PubMed ID: 16504693
[TBL] [Abstract][Full Text] [Related]
10. Long-term changes in bone mineral density in kidney transplant recipients.
Naylor KL; Garg AX; Hodsman AB; Rush DN; Leslie WD
Transplantation; 2014 Dec; 98(12):1279-85. PubMed ID: 25050472
[TBL] [Abstract][Full Text] [Related]
11. A randomized controlled trial to compare the efficacy of cyclical parathyroid hormone versus cyclical parathyroid hormone and sequential calcitonin to improve bone mass in postmenopausal women with osteoporosis.
Hodsman AB; Fraher LJ; Watson PH; Ostbye T; Stitt LW; Adachi JD; Taves DH; Drost D
J Clin Endocrinol Metab; 1997 Feb; 82(2):620-8. PubMed ID: 9024265
[TBL] [Abstract][Full Text] [Related]
12. Age at transplant--one of the factors affecting bone mineral density in kidney recipients--a single-center retrospective study.
Huang WH; Lai PC
Ren Fail; 2011; 33(8):776-80. PubMed ID: 21777172
[TBL] [Abstract][Full Text] [Related]
13. Evolution of bone disease at 2 years after transplantation: a single-center study.
Falkiewicz K; Boratyńska M; Zmonarski SC; Milewicz A; Patrzałek D; Biecek P; Klinger M
Transplant Proc; 2009 Oct; 41(8):3063-6. PubMed ID: 19857677
[TBL] [Abstract][Full Text] [Related]
14. Strategy of aggressive steroid weaning and routine alendronate therapy to reduce bone loss after cardiac transplantation.
Yong G; Hayes H; O'Driscoll G
Transplant Proc; 2007 Dec; 39(10):3340-3. PubMed ID: 18089383
[TBL] [Abstract][Full Text] [Related]
15. Comparison of alendronate and intranasal calcitonin for treatment of osteoporosis in postmenopausal women.
Downs RW; Bell NH; Ettinger MP; Walsh BW; Favus MJ; Mako B; Wang L; Smith ME; Gormley GJ; Melton ME
J Clin Endocrinol Metab; 2000 May; 85(5):1783-8. PubMed ID: 10843152
[TBL] [Abstract][Full Text] [Related]
16. Skeletal effects of cyclic recombinant human growth hormone and salmon calcitonin in osteopenic postmenopausal women.
Holloway L; Kohlmeier L; Kent K; Marcus R
J Clin Endocrinol Metab; 1997 Apr; 82(4):1111-7. PubMed ID: 9100582
[TBL] [Abstract][Full Text] [Related]
17. Effect of bisphosphonates on bone mineral density after renal transplantation as assessed by bone mineral densitometry.
Nayak B; Guleria S; Varma M; Tandon N; Aggarwal S; Bhowmick D; Agarwal SK; Mahajan S; Gupta S; Tiwari SC
Transplant Proc; 2007 Apr; 39(3):750-2. PubMed ID: 17445589
[TBL] [Abstract][Full Text] [Related]
18. The effect of intranasal salmon calcitonin therapy on bone mineral density in idiopathic male osteoporosis without vertebral fractures--an open label study.
Tóth E; Csupor E; Mészáros S; Ferencz V; Németh L; McCloskey EV; Horváth C
Bone; 2005 Jan; 36(1):47-51. PubMed ID: 15664001
[TBL] [Abstract][Full Text] [Related]
19. The effects of daily alendronate, daily calcitonin and alendronate every other day on bone mineral density in osteoporotic men.
Guven Z; Karadag-Saygi E; Unlu-Ozkan F; Akyuz G
Aging Male; 2007 Dec; 10(4):197-201. PubMed ID: 18033629
[TBL] [Abstract][Full Text] [Related]
20. Cyclosporine bone remodeling effect prevents steroid osteopenia after kidney transplantation.
Westeel FP; Mazouz H; Ezaitouni F; Hottelart C; Ivan C; Fardellone P; Brazier M; El Esper I; Petit J; Achard JM; Pruna A; Fournier A
Kidney Int; 2000 Oct; 58(4):1788-96. PubMed ID: 11012914
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
